SLC2A1 and metastatic malignant neoplasm in the lymph nodes: There were no significant differences in the expressions other five genes, COL1A2, PSAT1, SLC2A1, GCLM, and TTYH2 in terms depth of myometrial invasion, LVSI status, tumor histological grade, status of lymph node metastasis, and FIGO stage.